Successful Craniotomy for Advanced Basal Cell Carcinomas with Cranial Bone Invasion and Dura Mater Infiltration - Unique Presentation in a Bulgarian Patient
DOI:
https://doi.org/10.3889/oamjms.2018.101Keywords:
Surgery, Craniotomy, Basal cell carcinomas, Treatment outcome, Treatment approachAbstract
BACKGROUND: Basal cell carcinomas (BCC) located in the sun-exposed regions are a serious therapeutic challenge. Therefore early diagnosis and adequate therapy should be of a high priority for every dermatologic surgeon.
CASE PRESENTATION: We are presenting a patient with multiple BCCs, located on the area of the scalp, who had been treated several years ago with electrocautery and curettage after histopathological verification. However, the last few years the tumours have advanced, infiltrating firstly the tabula external and a year later the tabula interna of the cranium. A computed -tomography (CT) imaging and radiography of the skull were performed to reveal the definite tumour localisation, needed for planning an one - step surgical intervention. Both of the instrumental examinations confirmed the existence of osteolytic tumour lesions. Craniotomy with precise removal of the BCCs infiltrating the cranial bone in all of its thickness was performed. Partial resection of dura mater was also performed also because intraoperative findings established the involvement of the dura. Histopathological verification revealed bone and dural invasion with clean resection margins. The bone defect was recovered with hydroxyapatite cement. Reconstruction as the shape of the skull was carefully modified and adapted to its initial size and form. Layered closure of the skin and soft tissues were performed after the complete removal of the BCCs. The postoperative period had no serious complications.
CONCLUSION: Precisely managed therapy of BCC is curative in most of the cases as it ensures good prognosis for the patient.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Lima NL, Verli FD, de Miranda JL, Marinho SA. Basosquamous Carcinoma: Histopathological Features. Indian Journal of Dermatology. 2012; 57(5):382-383. https://doi.org/10.4103/0019-5154.100489 PMid:23112359 PMCid:PMC3482802
Wong CSM, Strange RC, Lear JT. Basal cell carcinoma. BMJ : British Medical Journal. 2003; 327(7418):794-798. https://doi.org/10.1136/bmj.327.7418.794 PMid:14525881 PMCid:PMC214105
Marzuka AG, Book SE. Basal Cell Carcinoma: Pathogenesis, Epidemiology, Clinical Features, Diagnosis, Histopathology, and Management. The Yale Journal of Biology and Medicine. 2015; 88(2):167-179. PMid:26029015 PMCid:PMC4445438
Situm M, Buljan M, Bulat V, Lugović Mihić L, Bolanca Z, Simić D. The role of UV radiation in the development of basal cell carcinoma. Coll Antropol. 2008; 32(Suppl 2):167-70. PMid:19138022
Donald PJ, Boggan J, Farwell DG, Enepekides DJ. Skull Base Surgery for the Management of Deeply Invasive Scalp Cancer. Skull Base. 2011; 21(6):343-350. https://doi.org/10.1055/s-0031-1284216 PMid:22547959 PMCid:PMC3312126
Morselli P, Tosti A, Guerra L, Fanti PA, Fedeli F, Pistorale T, Cavina C,Varotti C. Recurrent basal cell carcinoma of the back infiltrating the spine.Recurrent basal cell carcinoma. J Dermatol Surg Oncol. 1993; 19(10):917-22. https://doi.org/10.1111/j.1524-4725.1993.tb00979.x PMid:8408910
Berking C, Hauschild A, Kölbl O, Mast G, Gutzmer R. Basal Cell Carcinoma—Treatments for the Commonest Skin Cancer. Deutsches Ärzteblatt International. 2014; 111(22):389-395. PMid:24980564 PMCid:PMC4078227
Bichakjian CK, Olencki T, Aasi SZ, Alam M, Andersen JS, Berg D, Bowen GM,Cheney RT, Daniels GA, Glass LF, Grekin RC, Grossman K, Higgins SA, Ho AL, Lewis KD, Lydiatt DD, Nehal KS, Nghiem P, Olsen EA, Schmults CD, Sekulic A, Shaha AR,Thorstad WL, Tuli M, Urist MM, Wang TS, Wong SL, Zic JA, Hoffmann KG, Engh A.Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016; 14(5):574-97. https://doi.org/10.6004/jnccn.2016.0065 PMid:27160235
DI Stefani A, Del Regno L, Piccerillo A, Peris K. Practical indications for the management of non-melanoma skin cancer patients. G Ital Dermatol Venereol. 2017; 152(3):286-294. PMid:28195452
Patel SS, Cliff Sh, Ward Booth P. Incomplete removal of basal cell carcinoma: what is the value of further surgery? Oral and Maxillofacial Surgery. 2013; 17(2):115-118. https://doi.org/10.1007/s10006-012-0348-3 PMid:22868984 PMCid:PMC3661037
Clark CM, Furniss M, Mackay-Wiggan JM. Basal cell carcinoma: an evidence-based treatment update. Am J Clin Dermatol. 2014; 15(3):197-216. https://doi.org/10.1007/s40257-014-0070-z PMid:24733429
Berking C, Hauschild A, Kölbl O, Mast G, Gutzmer R. Basal Cell Carcinoma—Treatments for the Commonest Skin Cancer. Deutsches Ärzteblatt International. 2014; 111(22):389-395. PMid:24980564 PMCid:PMC4078227
Lanoue J, Goldenberg G. Basal Cell Carcinoma: A Comprehensive Review of Existing and Emerging Nonsurgical Therapies. The Journal of Clinical and Aesthetic Dermatology. 2016; 9(5):26-36. PMid:27386043 PMCid:PMC4928477
Khan L, Breen D, Zhang L, et al. Predictors of recurrence after radiotherapy for non-melanoma skin cancer. Current Oncology. 2014; 21(2):e326-e329. https://doi.org/10.3747/co.21.1727 PMid:24764714 PMCid:PMC3997462
Lee WR, Mendenhall WM, Parsons JT, Million RR. Radical radiotherapy for T4 carcinoma of the skin of the head and neck: a multivariate analysis. Head Neck. 1993; 15(4):320-4. https://doi.org/10.1002/hed.2880150409 PMid:8360054
Trakatelli M, Morton C, Nagore E, Ulrich C, Del Marmol V, Peris K, Basset-Seguin N. Update of the European guidelines for basal cell carcinoma management. European Journal of Dermatology. 2014; 24(3):312-29.17. Love WE, Bernhard JD, Bordeaux JS. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review. Arch Dermatol. 2009; 145(12):1431-8.
Ericson MB, Wennberg A-M, Larkö O. Review of photodynamic therapy in actinic keratosis and basal cell carcinoma. Therapeutics and Clinical Risk Management. 2008; 4(1):1-9.
Silapunt S, Chen L, Migden MR. Hedgehog pathway inhibition in advanced basal cell carcinoma: latest evidence and clinical usefulness. Therapeutic Advances in Medical Oncology. 2016; 8(5):375-382. https://doi.org/10.1177/1758834016653605 PMid:27583029 PMCid:PMC4981290
Kleydman Y, Manolidis S, Ratner D. Basal cell carcinoma with intracranial invasion. J Am Acad Dermatol. 2009; 60(6):1045-9. https://doi.org/10.1016/j.jaad.2008.10.005 PMid:19467376
Kwon CS, Al Awar O, Ripa V, Said G, Rocka S. Basal cell carcinoma of the scalp with destruction and invasion into the calvarium and dura mater: Report of 7 cases and review of literature. Journal of Clinical Neuroscience. 2018; 47:190-7. https://doi.org/10.1016/j.jocn.2017.09.028 PMid:29074315
Wei FC, Tsao SB, Chang CN, Noordhoff MS. Scalp, skull, and dura reconstruction on an emergency basis. Ann Plast Surg. 1987; 18(3):252-6. https://doi.org/10.1097/00000637-198703000-00014 PMid:3592514
Lutz BS, Wei FC, Chen HC, Lin CH, Wei CY. Reconstruction of scalp defects with free flaps in 30 cases. Br J Plast Surg. 1998; 51(3):186-90. https://doi.org/10.1054/bjps.1997.0182 PMid:9664876
Wang HT, Erdmann D, Olbrich KC, Friedman AH, Levin LS, Zenn MR. Free flap reconstruction of the scalp and calvaria of major neurosurgical resections in cancer patients: lessons learned closing large, difficult wounds of the dura and skull. Plast Reconstr Surg. 2007; 119(3):865-72. https://doi.org/10.1097/01.prs.0000240830.19716.c2 PMid:17312489
Çöloğlu H, Özkan B, Şener M, Uysal AÇ, Borman H. The management of non-melanocytic skin malignancies of the scalp and calvarium. Indian Journal of Plastic Surgery : Official Publication of the Association of Plastic Surgeons of India. 2014; 47(1):36-42. https://doi.org/10.4103/0970-0358.129621 PMid:24987202 PMCid:PMC4075214
Nahhas AF, Scarbrough CA, Trotter S. A Review of the Global Guidelines on Surgical Margins for Nonmelanoma Skin Cancers. The Journal of Clinical and Aesthetic Dermatology. 2017; 10(4):37-46. PMid:28458773 PMCid:PMC5404779
Deshmukh P, Sharma YK, Dogra BB, Chaudhari ND. Superficial Large Basal Cell Carcinoma Over Face, Reconstructed by V-Y Plasty. Journal of Cutaneous and Aesthetic Surgery. 2014; 7(1):65-66. https://doi.org/10.4103/0974-2077.129992 PMid:24761108 PMCid:PMC3996799
Ruini C, Hartmann D, Saral S, Krammer S, Ruzicka T, von Braunmühl T. The invisible basal cell carcinoma: how reflectance confocal microscopy improves the diagnostic accuracy of clinically unclear facial macules and papules. Lasers Med Sci. 2016; 31(8):1727-1732. https://doi.org/10.1007/s10103-016-2043-3 PMid:27492373
Puig S, Berrocal A. Management of high-risk and advanced basal cell carcinoma. Clin Transl Oncol. 2015; 17(7):497-503. https://doi.org/10.1007/s12094-014-1272-9 PMid:25643667 PMCid:PMC4495248
Mahvash M. Intracranial basal cell carcinoma with extensive invasion of the skull base. Turk Neurosurg. 2014; 24(4):571-3. https://doi.org/10.5137/1019-5149.JTN.8612-13.0
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0